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Introduction {#sec005}
============

*Helicobacter pylori* is strongly associated with gastroduodenal diseases, such as chronic gastritis, peptic ulcer, duodenal ulcer and gastric cancer \[[@pone.0166835.ref001]\]. In fact, this bacteria has been classified as a group I carcinogen by the International Agency for Research on Cancer \[[@pone.0166835.ref002]\]. Although *H*. *pylori* is susceptible to most antibiotics *in vitro*, only few antibiotics can be used for eradicating *H*. *pylori in vivo*, e.g. amoxicillin, clarithromycin, metronidazole and tetracycline \[[@pone.0166835.ref003]\]. Combination therapy is needed for successful eradication of *H*. *pylori*, Increasing prevalence of antibiotic resistance in *H*. *pylori* is problematic since it is one of the important causes of therapy failure \[[@pone.0166835.ref004]\]. The ability of *H*. *pylori* to form biofilm *in vitro* and also *in vivo* has been demonstrated \[[@pone.0166835.ref005]--[@pone.0166835.ref007]\]. *H*. *pylori* formed biofilm within *in vivo* environment especially gastric mucosa had been well demonstrated by previous study \[[@pone.0166835.ref007]\]. The formation of biofilm within *in vivo* environment was believed to be one of the factors which cause *H*. *pylori* eradication failure \[[@pone.0166835.ref007]\].

According to Donlan *et al*. (2002) \[[@pone.0166835.ref008]\], biofilms are defined as complex microbial ecosystems adherent to each other and/or to surface or interface. It is a microbially derived sessile community characterized by cells that are embedded in a matrix of extracellular polymeric substances that they have produced, and exhibit an altered phenotype with respect to growth rate and gene transcription \[[@pone.0166835.ref008]\]. Biofilms are important in bacterial pathogenesis as they plays a central role in helping microbes survive or spread within the host. This is because the biofilm matrix acts as shield, protecting bacteria from host defenses and antibiotics \[[@pone.0166835.ref009],[@pone.0166835.ref010]\]. Bacterial biofilm can be 10 to 1000 times less susceptible to antimicrobial substances than the same organism in suspension \[[@pone.0166835.ref011]\]. Biofilm formation makes it difficult for antibiotics to reach the bacteria, underneath aiding the development of antibiotic resistance and increase the risk of treatment failure \[[@pone.0166835.ref008]\]. Therefore, biofilms are often associated with chronic infections \[[@pone.0166835.ref012]\]. Cammarota *et al*. demonstrated that *H*. *pylori* biofilm on the gastric mucosa epithelium was associated with eradication failure and N-acetylcysteine pretreatment before antibiotic therapy was effective in overcoming antibiotic resistance \[[@pone.0166835.ref013],[@pone.0166835.ref014]\].

The ability of biofilm formation in bacteria is genetically controlled \[[@pone.0166835.ref015]--[@pone.0166835.ref019]\]. Based on previous studies, one of the most common genes associated with biofilm formation in bacteria (including *H*. *pylori*, *S*. *mutans* and *L*. *monocytogenes*) is the *luxS* gene \[[@pone.0166835.ref015]--[@pone.0166835.ref017]\]. Apart from *luxS* gene, few other genes have also been reported to be associated with biofilm formation in different bacteria \[[@pone.0166835.ref018],[@pone.0166835.ref019]\]. According to Yoshida and Kuramitsu (2002) \[[@pone.0166835.ref020]\], *dgk*, *sgp* and *com* also play a role in *S*. *mutans* biofilm formation. Wu and colleagues \[[@pone.0166835.ref021]\] revealed that *treC* and *sugE* affect biofilm formation in *K*. *pneumoniae* by modulating capsular polysaccharide synthesis production. Taken together, biofilm formation in bacteria may be regulated by multiple genes working together.

Despite extensive studies conducted on *H*. *pylori* biofilm formation, precisely how genetic differences of different *H*. *pylori* strains influence biofilm formation remains not well-established. The objective of this study is to identify genes associated with *H*. *pylori* biofilm formation.

Materials and Methods {#sec006}
=====================

*H. pylori* strains {#sec007}
-------------------

*H*. *pylori* standard strain J99 (ATCC 700824) was obtained from the American Type Culture Collection (USA). The *H*. *pylori* clinical strains used in this study were from the *H*. *pylori* collection of the *Helicobacter* Research Laboratory at the University of Malaya (Malaysia).

*H*. *pylori* strain 26695 (ATCC 70392) *cagA* and *cag*PAI deletion mutants were constructed using the PCR-based method as described by Chalker *et al*. \[[@pone.0166835.ref022]\] and Tan and Berg (2004) \[[@pone.0166835.ref023]\] in A/Prof. Ho Bow's laboratory at the Department of Microbiology (National University of Singapore, Singapore).

Culturing of the *H*. *pylori* and biofilm {#sec008}
------------------------------------------

*H*. *pylori* were cultured on non-selective chocolate blood agar plate and incubated in a humidified incubator with 10% CO2 at 37°C for three days. The 3-days old *H*. *pylori* plate cultures were harvested with a sterile cotton swab and emulsified in brain heart infusion (BHI) broth (Oxoid, Hampshire, UK) supplemented with 1% β-cyclodextrin (Sigma-Aldrich, St. Louis, MO, USA) and 0.4% yeast extract (Oxoid, Hampshire, UK). After 3 days incubation, the total bacterial population of each of the cultures was standardized with the same bacterial turbidity value (bacterial turbidity = 0.042). Following which, 500 μl of bacterial suspension was then inoculated into each well of a 24-well tissue culture plate (BD Falcon, Franklin Lakes, NJ, USA). BHI broth without *H*. *pylori* served as a negative control. The growth of the biofilm was observed at the day 3, day 5, day 7 and day 14 with the amount of biofilm formed analyzed based on crystal violet staining.

At each time interval, the bacterial suspensions of the 24-well tissue culture plate were first aspirated out. An aliquot of 650μl of 0.1% crystal violet (Friendemann Schmidt, WA, Australia) was added to each well and the plate was gently swirled for 30 minutes to ensure uniform staining of the biofilm. The excess crystal violet stain was removed and the wells were washed thoroughly using 800μl sterile distilled water to remove any excess crystal violet stain. The crystal-violet stained biofilm was finally destained using 1ml of 95% ethanol (VWR Prolabo, Lutterworth)-5% acetic acid (Friendemann Schmidt, WA, Australia) which serve as destaining solution. The solution collected was measured at OD~600nm~ on a SmartSpec Plus spectrophotometer (Bio-Rad, Hercules, CA, USA). The amount of crystal violet absorbed by the biofilm (CV~600nm~) was determined by taking the mean absorbance value. All experiments were performed technical triplicates and in difference day of biological triplicates.

At the same time, bacterial turbidity value of each bacteria strains were taken for every time points. The bacterial turbidity value of each strain was taken in order to determine the growth rate of the strains. All experiments were performed in biological and technical triplicates and specific biofilm unit (CV~600nm~ /OD~600nm~) value was calculated.

Illumina Library Preparation and Sequencing {#sec009}
-------------------------------------------

DNA was extracted from 3-day old *H*. *pylori* using the Bacterial DNA mini kit (Stratec Molecular, Berlin, Germany) according to the manufacturer's instructions. Illumina sequencing library was prepared and samples were sequenced on a MiSeq sequencer (Illumina, San Diego, CA, USA) as described in Perkins *et al*. \[[@pone.0166835.ref024]\]. Sequences used in this study have been deposited with GenBank under accession numbers listed in **[Table 1](#pone.0166835.t001){ref-type="table"}**.

10.1371/journal.pone.0166835.t001

###### Accession numbers and details of *H*. *pylori* genomic sequences used in this study.

![](pone.0166835.t001){#pone.0166835.t001g}

  Strain   Accession no.   Genome size (bp)   Genes   Proteins   %GC    Contigs   Max length (bp)   N50 (bp)    Coverage   Ref
  -------- --------------- ------------------ ------- ---------- ------ --------- ----------------- ----------- ---------- ----------------------------------------------------
  J99      NC_000921       1,643,831          1,559   1,471      39.2   1         1,643,831         1,643,831   \-         Alm *et al*, 1999 \[[@pone.0166835.ref025]\]
  UM032    NC_021215       1,593,537          1549    1438       38.8   1         1,593,537         1,593,537   \-         Yalda *et al*., 2013 \[[@pone.0166835.ref026]\]
  UM023    AUSK00000000    1,624,154          1,562   1,518      38.7   34        485,260           183,178     \-         Rehvathy *et al*., 2013 \[[@pone.0166835.ref027]\]
  UM037    AUSI00000000    1,724,611          1,645   1,574      38.9   60        234,132           80,609      \-         Rehvathy *et al*., 2013
  UM065    AUSM00000000    1,587,249          1,500   1,461      38.9   39        334,064           163,534     \-         Rehvathy *et al*., 2013
  UM066    AUSJ00000000    1,694,309          1,590   1,562      38.6   34        319,894           146,858     \-         Rehvathy *et al*., 2013
  UM077    AUSQ00000000    1,620,877          1,565   1,527      38.8   53        328,671           187,040     \-         Rehvathy *et al*., 2013
  UM085    AUSP00000000    1,645,640          1,568   1,524      38.7   50        341,517           94,888      \-         Rehvathy *et al*., 2013
  UM111    AUSR00000000    1,663,383          1,581   1,536      38.7   38        245,602           110,134     \-         Rehvathy *et al*., 2013
  UM045    AONO00000000    1,602,114          1,559   1,439      39.0   20        110,455           146,660     158        This study
  UM054    AONL00000000    1,594,474          1,570   1,422      39.1   81        103,788           39,593      148        This study
  UM087    LFDR00000000    1,657,861          1,610   1,456      38.9   17        260,866           153,641     166        This study
  UM119    LFBY00000000    1,592,071          1,564   1,439      38.8   18        266,685           153,847     153        This study
  UM122    LFBX00000000    1,593,819          1,556   1,427      39.1   23        346,159           96,269      124        This study
  UM131    LFBZ00000000    1,598,266          1,551   1,422      39.2   16        375,408           158,380     151        This study
  UM139    LFCA00000000    1,617,602          1,574   1,454      38.9   20        231,133           90,197      180        This study
  UM147    LFLE00000000    1,633,271          1,567   1,442      39.5   58        272,592           145,059     153        This study
  UM152    LFIS00000000    1,633,599          1,568   1,445      39.0   16        434,701           188,275     169        This study
  UM158    LFCB00000000    1,634,841          1,588   1,448      38.9   27        240,532           185,427     153        This study
  UM163    LFJR00000000    1,656,598          1,601   1,475      38.5   16        314,921           140,690     175        This study
  UM165    LFIR00000000    1,651,447          1,611   1,471      38.9   20        414,265           125,433     116        This study
  UM202    LFKE00000000    1,672,999          1,664   1,494      38.9   62        117,987           40,452      214        This study
  UM246    LFKI00000000    1,644,161          1,592   1,466      38.6   16        277,351           174,853     200        This study
  UM276    LJXI00000000    1,666,681          1,689   1,512      38.8   61        330,937           158,795     157        This study
  UM291    LFKJ00000000    1,569,053          1,547   1,418      38.8   28        219,046           123,332     135        This study
  UM300    LFIT00000000    1,591,764          1,535   1,410      39.2   14        259,105           193,002     142        This study
  UM352    LFKK00000000    1,623,273          1,573   1,443      38.7   19        330,865           156,967     202        This study
  UM370    LFKL00000000    1,582,384          1,552   1,422      38.7   23        200,250           93,564      174        This study
  UM408    LFIU00000000    1,576,513          1,524   1,391      39.1   26        265,219           111,980     253        This study
  UM411    LFKM00000000    1,631,715          1,582   1,440      39.0   17        271,501           151,419     201        This study
  UM520    LEOV00000000    1,617,859          1,605   1,444      38.7   51        177,886           52,801      160        This study

Identifying genes associated with biofilm formation {#sec010}
---------------------------------------------------

Biofilm forming ability of *H*. *pylori* standard strains J99 and 31 sequenced clinical strains were determined. Based on highest biofilm specific unit value, there strains were classified into 3 groups (good, moderate and poor biofilm formers. Cumulative frequency (%) was calculated using the formula: $$cumulative\ frequency\ \left( \% \right)for\ 32\ strains = a + \left( \frac{x}{32} \times 100 \right)$$ Where,

a = previous cumulative frequency;

x = number of strains which showed the particular highest biofilm specific unit value

The rate of biofilm formation for each of the strains was determined by using the formula below: $$Rate\ of\ biofilm\ formation = \frac{biofilm\ formation\ day\ b - biofilm\ formation\ day\ a}{day\ b - day\ a}$$

*H*. *pylori* genomic sequences were annotated and compared using RAST (Rapid Annotation using Subsystem Technology) (<http://rast.nmpdr.org/>) \[[@pone.0166835.ref028]--[@pone.0166835.ref030]\]. Sequence-based comparison among *H*. *pylori* strains was carried out using the SEED viewer of RAST with percentage similarity above 80% was used. Two-tailed Fisher's exact test was carried out using SPSS (IBM statistic 20, Armonk, New York, USA). P-value \<0.05 was considered statistically significant.

Next, the presence and absence of genes-of-interest identified by comparative genomic analysis were confirmed by conventional end-point PCR using primers and conditions listed in **[Table 2](#pone.0166835.t002){ref-type="table"}**.

10.1371/journal.pone.0166835.t002

###### Primers used for amplification of *H*. *pylori* biofilm genes.

![](pone.0166835.t002){#pone.0166835.t002g}

  Gene                                 Primer sequence (5'- 3')          Product size (bp)   PCR condition
  ------------------------------------ --------------------------------- ------------------- ----------------------------------------------------------------
  hypothetical protein K747_10375      Forward: `CATCTCGCGTGATGGGGT`     426                 95°C, 5min; 35x (95°C, 30s; 53°C, 30s; 72°C, 1min); 72°C, 7min
                                       Reverse: `TCTTCTTGCTTTTTGGCGAT`                       
  hypothetical protein K747_09130      Forward: `GAGTGGGATAGAGTTAGAAC`   777                 95°C, 5min; 35x (95°C, 30s; 60°C, 30s; 72°C, 1min); 72°C, 7min
                                       Reverse: `GTATTAGCCGCTGCTTC`                          
  flagellar protein                    Forward: `GTGAGTTGTGCATACGCT`     388                 95°C, 5min; 35x (95°C, 30s; 51°C, 30s; 72°C, 1min); 72°C, 7min
                                       Reverse: `AGGCCACTGAGTTTTTAGGT`                       
  alpha-(1,3)-fucosyltransferase       Forward: `TCCAGCCCTTACTAGACGCT`   1279                95°C, 5min; 35x (95°C, 30s; 57°C, 30s; 72°C, 1min); 72°C, 7min
                                       Reverse: `AGCTCCAAAAGAGGGGTAGC`                       
  hypothetical protein K747_06625      Forward: `GGCTCACCACTATACCGCTT`   1089                95°C, 5min; 35x (95°C, 30s; 57°C, 30s; 72°C, 1min); 72°C, 7min
                                       Reverse: `TGACCGGCTCTTTTGTGTCA`                       
  outer membrane protein (*homD*)      Forward: `GACGCTCAAGGCAAGGTAGT`   1409                95°C, 5min; 35x (95°C, 30s; 57°C, 30s; 72°C, 1min); 72°C, 7min
                                       Reverse: `AACACATCCATTCCCCCACC`                       
  *cag* pathogenicity island protein   Forward: `AACGCTCCATCAAGAGCCAA`   1332                95°C, 5min; 35x (95°C, 30s; 57°C, 30s; 72°C, 1min); 72°C, 7min
                                       Reverse: `CCCGCTCTTGCTTCCTTACT`                       

Scanning electron microscopy (SEM) {#sec011}
----------------------------------

Scanning Electron Microscopy (SEM) was performed as described by Lemos et al. (2004) with modifications \[[@pone.0166835.ref031]\]. The biofilms were grown on the coverslips (**[Fig 1](#pone.0166835.g001){ref-type="fig"}**). The coverslips were washed 2 times in sterile phosphate buffered saline (PBS). The coverslips were then fixed with 2% (wt/vol) glutaraldehyde in 0.1 M PBS (pH 7.4) and post-fixed with 1% osmium tetroxide in 0.1M phosphate buffered saline. The fixed cells were washed with 0.1 M PBS and dehydrated with 50%, 75%, 95%, 100% ethanol. The samples were dried using critical point dryer (Bal-Tec CPD 0300) and examined using JSM-5600 scanning electron microscope (JEOL, Peabody, MA, USA) operating at 10kV.

![SEM of *H*. *pylori* biofilm strain 26695 on coverslip.\
(A) Diagrammatic illustration of *H*. *pylori* biofilm formation on coverslip. (B) Section of *H*. *pylori* at the air medium interface, showing biofilm formation on day 14 (x50). (C) Enlarged section of *H*. *pylori* biofilm formed at the air medium interface (x4,500). (D) Enlarged section of *H*. *pylori* biofilm showing the presence of film like structures (x10,000). Blue arrow indicate the film-like structures postulated to be exopolysaccharides and red arrow indicate spiral *H*. *pylori*.](pone.0166835.g001){#pone.0166835.g001}

Results {#sec012}
=======

Optimization of conditions for *in vitro* biofilm formation {#sec013}
-----------------------------------------------------------

*H*. *pylori* biofilm formation was observable at the air-liquid interface of wells after three days of incubation in a humidified 10% CO2 incubator at 37°C. Optimum conditions for biofilm formation were chosen based on maximum biofilm formation without compromising bacterial growth. Comparing between different concentrations of β-cyclodextrin (0.5% to 2.0%) and fetal bovine serum (5% to 15%) as supplement to BHI broth, 1% β-cyclodextrin was shown to be optimum for biofilm formation. Biofilm formation in BHI with 1% β-cyclodextrin broth showed at least one-fold higher than BHI supplemented with fetal bovine serum (5% to 15%) and β-cyclodextrin (0.5% and 2.0%). Biofilm formation in microaerophilic condition was shown to be 3-fold higher than ambient atmospheric condition. As osmolality of the medium was increased (from original 0.5% to 1% and 2% sodium chloride), biofilm formation and specific biofilm unit were reduced. In addition, the optimum condition for both biofilm formation and growth occurred at pH 7.0. Thus, BHI broth supplemented with 0.4% yeast extract and 1% β-cyclodextrin at pH 7.0 and microaerophilic condition was determined to be optimum for the study of biofilm formation of *H*. *pylori* in this study.

Identification of genes associated with biofilm formation {#sec014}
---------------------------------------------------------

The median biofilm specific unit value (cumulative frequency = 50%) was determined to be between specific biofilm unit of 1.0 and 1.1. Strains producing biofilm with specific biofilm unit \<1.0 were classified as poor biofilm formers while those \>1.1 were classified as good biofilm formers. Those specific biofilm units between 1.0 and 1.1 were classified as moderate biofilm formers. Twelve (37.5%) of the tested strains were classified as good biofilm formers, while another 12 (37.5%) strains were poor biofilm formers. The remaining 8 (25.0%) strains were moderate biofilm formers (**[Table 3](#pone.0166835.t003){ref-type="table"}**). Highest specific biofilm unit was shown to be significantly different between poor, moderate and good biofilm formers (one-way ANNOVA p-value = 0.001).

10.1371/journal.pone.0166835.t003

###### Classification of *H*. *pylori* strains based on highest specific biofilm unit.

One-way ANOVA was used to demonstrate statistically significant differences in highest specific biofilm unit between poor, moderate and good biofilm formers (p-value = 0.001).

![](pone.0166835.t003){#pone.0166835.t003g}

  Strain   Highest specific biofilm unit (CV~600nm~ /OD~600nm~)   Cumulative frequency (%)   BF Group
  -------- ------------------------------------------------------ -------------------------- ----------
  UM045    0.6                                                    3.2                        Poor
  UM131    0.7                                                    9.5                        Poor
  UM411    0.7                                                    9.5                        Poor
  UM147    0.8                                                    15.7                       Poor
  UM152    0.8                                                    15.7                       Poor
  UM054    0.9                                                    25.1                       Poor
  UM037    0.9                                                    25.1                       Poor
  UM300    0.9                                                    25.1                       Poor
  UM202    1.0                                                    40.7                       Moderate
  UM065    1.0                                                    40.7                       Moderate
  UM158    1.0                                                    40.7                       Moderate
  UM276    1.0                                                    40.7                       Moderate
  UM408    1.0                                                    40.7                       Moderate
  UM023    1.1                                                    62.6                       Moderate
  UM165    1.1                                                    62.6                       Moderate
  UM520    1.1                                                    62.6                       Moderate
  UM246    1.1                                                    62.6                       Moderate
  UM370    1.1                                                    62.6                       Moderate
  UM291    1.1                                                    62.6                       Moderate
  UM139    1.1                                                    62.6                       Moderate
  UM352    1.3                                                    72.0                       Good
  UM122    1.3                                                    72.0                       Good
  UM032    1.4                                                    75.1                       Good
  UM087    1.5                                                    81.4                       Good
  J99      1.5                                                    81.4                       Good
  UM163    1.6                                                    84.5                       Good
  UM119    1.7                                                    87.6                       Good
  UM085    2.4                                                    90.7                       Good
  UM077    4.0                                                    93.9                       Good
  UM066    4.9                                                    97.0                       Good
  UM111    5.0                                                    100.0                      Good

Median highest specific biofilm unit between 1.0 and 1.1 was classified as moderate biofilm formers. Highest specific biofilm unit shown represent average of triplicates. BF: biofilm former

Based on rate of biofilm formation from day 0 to day 7, there was clear segregation between poor and good biofilm forming strains (**[Table 4](#pone.0166835.t004){ref-type="table"}**). Student's t-test revealed that there were significant differences in rate of biofilm formation between poor, moderate and good biofilm forming strains across all time point (p-value \<0.05), except between poor and moderate groups at day 3 to day 5 (p-value = 0.260). While good and poor biofilm forming strains displayed relatively consistent rate of biofilm formation across 7 days, moderate biofilm forming strains varied in rate of biofilm formation across time course of study. The moderate biofilm forming strains showed either declined biofilm forming rate by day 3 or delayed optimum biofilm formation starting from day 3 onwards. The rate of biofilm formation profiles was consistent with the highest specific biofilm unit profiles across multiple *H*. *pylori* strains.

10.1371/journal.pone.0166835.t004

###### The rate of biofilm formation for all the *H*. *pylori* strains which were used in this study.

Statistical significance for differences in rate of biofilm formation across time points was determined by two-tailed Student's t-test.

![](pone.0166835.t004){#pone.0166835.t004g}

  Strain                     BF Group   Rate of biofilm formation (biofilm formation per day)                                                  
  -------------------------- ---------- ------------------------------------------------------- ---------------------------------------------- ----------------------------------------------
  UM045                      Poor       0.012                                                   0.023                                          0.010
  UM131                      Poor       0.018                                                   0.012                                          0.022
  UM411                      Poor       0.021                                                   0.022                                          0.019
  UM147                      Poor       0.018                                                   0.108                                          0.032
  UM152                      Poor       0.016                                                   0.035                                          0.024
  UM054                      Poor       0.013                                                   0.112                                          0.033
  UM037                      Poor       0.012                                                   0.011                                          0.011
  UM300                      Poor       0.015                                                   0.011                                          0.011
  UM202                      Moderate   0.025                                                   0.035                                          0.128
  UM065                      Moderate   0.100                                                   0.059                                          0.034
  UM158                      Moderate   0.100                                                   0.132                                          0.066
  UM276                      Moderate   0.027                                                   0.110                                          0.092
  UM408                      Moderate   0.080                                                   0.041                                          0.021
  UM023                      Moderate   0.019                                                   0.165                                          0.147
  UM165                      Moderate   0.022                                                   0.056                                          0.067
  UM520                      Moderate   0.030                                                   0.055                                          0.026
  UM246                      Moderate   0.032                                                   0.033                                          0.105
  UM370                      Moderate   0.103                                                   0.029                                          0.021
  UM291                      Good       0.039                                                   0.039                                          0.125
  UM139                      Good       0.018                                                   0.028                                          0.093
  UM352                      Good       0.091                                                   0.137                                          0.100
  UM122                      Good       0.127                                                   0.128                                          0.128
  UM032                      Good       0.134                                                   0.112                                          0.124
  UM087                      Good       0.136                                                   0.146                                          0.151
  J99                        Good       0.133                                                   0.133                                          0.157
  UM163                      Good       0.112                                                   0.100                                          0.119
  UM119                      Good       0.103                                                   0.112                                          0.099
  UM085                      Good       0.123                                                   0.120                                          0.089
  UM077                      Good       0.108                                                   0.113                                          0.118
  UM066                      Good       0.153                                                   0.148                                          0.136
  UM111                      Good       0.162                                                   0.158                                          0.151
  **Average**                                                                                                                                  
  *Poor BF*                  \-         0.016                                                   0.042                                          0.020
  *Moderate BF*              \-         0.050                                                   0.065                                          0.077
  *Good BF*                  \-         0.126                                                   0.128                                          0.125
  **Student's t-test**                                                                                                                         
  *Poor vs*. *Moderate BF*   \-         0.006[\*](#t004fn002){ref-type="table-fn"}              0.260                                          0.001[\*](#t004fn002){ref-type="table-fn"}
  *Moderate vs*. *Good BF*   \-         \<0.001[\*](#t004fn002){ref-type="table-fn"}            0.001[\*](#t004fn002){ref-type="table-fn"}     0.005[\*](#t004fn002){ref-type="table-fn"}
  *Poor vs*. *Good BF*       \-         \<0.001[\*](#t004fn002){ref-type="table-fn"}            \<0.001[\*](#t004fn002){ref-type="table-fn"}   \<0.001[\*](#t004fn002){ref-type="table-fn"}

Rate of biofilm formation shown represents average of triplicates; BF: biofilm former

\* p-value\<0.05 is considered statistically significant

Through the comparison of annotated genes present in *H*. *pylori* genomic sequences of poor, moderate and good biofilm forming strains, with 3 hypothetical genes (Hypothetical protein K747_10375, Hypothetical protein K747_09130 and Hypothetical protein K747_06625) and 4 functional genes (flagellar protein, *cag* pathogenicity island protein, outer membrane protein (*homD*) and alpha-(1,3)- fucosyltransferase) were identified to be significantly correlating with capability of forming biofilm (p-value \<0.05) (**[Table 5](#pone.0166835.t005){ref-type="table"}**). The presences and absences of these interested genes were verified by using PCR method (**[Table 5](#pone.0166835.t005){ref-type="table"}**). One of the genes identified is annotated as *cag* pathogenicity island protein. To confirm that *cag* pathogenicity island (*cag*PAI) genes were involved in *H*. *pylori* biofilm formation, biofilm formation by wild-type and deletion mutants of *cagA* and *cag*PAI were compared. Bacteria turbidity and biofilm formation were increasing day 3 to day 14 (**[Fig 2](#pone.0166835.g002){ref-type="fig"}**). This was consistent with observation by SEM that spiral form of *H*. *pylori* could still found in the biofilm on day 14. Deletion of *cagA* and *cag*PAI were demonstrated to reduce biofilm formation (**Figs [2](#pone.0166835.g002){ref-type="fig"}** and **[3](#pone.0166835.g003){ref-type="fig"}**). The microcolonies in the biofilm were denser and bigger in wild type as compared to Δ*cag*A and Δ*cag*PAI. *cag*PAI knockout mutants formed sparsely distributed microcolonies at the air-medium interface (**[Fig 3](#pone.0166835.g003){ref-type="fig"}**). At higher magnification, it was observed that the extracellular matrix formed by the wild-type strain was denser than that of Δ*cag*A and Δ*cag*PAI. In addition, extracellular matrix formed by Δ*cag*A was film-like in structure compared to the filament-like structure form by wild-type. Extracellular matrix was scanty in the biofilm of Δ*cag*PAI.

![Bacterial growth and biofilm formation by *H*. *pylori* 26695 wild-type, *cag*A and *cag*PAI deletion mutants.\
(A) Bacterial growth measured at OD600nm, (B) biofilm formation analyzed using crystal violet analysis and (C) specific biofilm unit. Specific biofilm unit is a representation of biofilm formation normalized with planktonic mass and is determined by dividing the absorbance of biofilm-bound crystal violet with the corresponding planktonic cell turbidity OD. Biofilm development of different *H*. *pylori* strains was monitored over a period of 14 days. Values and error bars represent means and standard deviations of measurements in triplicates. (\*) p\< 0.05 (2-tailed Student's *t* test).](pone.0166835.g002){#pone.0166835.g002}

![SEM of biofilm formed by 14-day old *H*. *pylori* 26695 wild-type, *cag*A and *cag*PAI deletion mutants.\
Biofilm formed by (A) wild type, (B) *cag*A and (C) *cag*PAI knockouts as observed under x50 and x4,500 magnification. The microcolonies in the biofilm were denser and bigger in wild type as compared to Δ*cag*A and Δ*cag*PAI. *cag*PAI knockout mutants formed sparsely distributed microcolonies at the air-medium interface.](pone.0166835.g003){#pone.0166835.g003}

10.1371/journal.pone.0166835.t005

###### Genes with significant association with biofilm formation (p-value \<0.05) confirmed by PCR.

![](pone.0166835.t005){#pone.0166835.t005g}

  Genes                                RefSeq reference no.   *Helicobacter pylori* strain (N = 32)   Fisher's exact test (p-value)                                                                                                        
  ------------------------------------ ---------------------- --------------------------------------- -------------------------------------------------------- --------------------------------------------------------------------------- ----------------------------------------------
  hypothetical protein K747_10375      WP_015645358.1         0                                       7 (58.3%)                                                12 (100%)                                                                   \<0.001[\*](#t005fn001){ref-type="table-fn"}
                                                                                                      UM065, UM276, UM023, UM520, UM246, UM370, UM291          UM122, UM032, UM087, J99, UM163, UM119, UM085, UM077, UM066, UM111, UM352   
  hypothetical protein K747_09130      WP_015645548.1         1 (12.5%)                               7 (58.3%)                                                11 (91.7%)                                                                  0.001[\*](#t005fn001){ref-type="table-fn"}
                                                              UM045                                   UM202, UM276, UM408, UM520, UM246, UM370, UM291          UM122, UM032, UM087, J99, UM163, UM119, UM085, UM077, UM066, UM111          
  hypothetical protein K747_06625      WP_015644951.1         1 (12.5%)                               8 (66.7%)                                                11 (91.7%)                                                                  \<0.001[\*](#t005fn001){ref-type="table-fn"}
                                                              UM045                                   UM202, UM158, UM408, UM246, UM023, UM520, UM139, UM291   UM122, UM032, UM087, J99, UM163, UM119, UM085, UM077, UM066, UM352          
  flagellar protein                    WP_000744159.1         1 (12.5%)                               8 (66.7%)                                                11 (91.7%)                                                                  \<0.001[\*](#t005fn001){ref-type="table-fn"}
                                                              UM045                                   UM202, UM065, UM158, UM408, UM023, UM165, UM370, UM139   UM122, UM032, UM087, J99, UM163, UM119, UM085, UM077, UM066, UM352          
  *cag* pathogenicity island protein   WP_015644978.1         0                                       7 (58.3%)                                                8 (66.7%)                                                                   0.005[\*](#t005fn001){ref-type="table-fn"}
                                                                                                      UM065, UM276, UM023, UM520, UM246, UM370, UM291          UM032, UM163, UM119, UM085, UM077, UM066, UM352                             
  outer membrane protein (*homD*)      WP_002205258.1         0                                       7 (58.3%)                                                10 (83.3%)                                                                  0.001[\*](#t005fn001){ref-type="table-fn"}
                                                                                                      UM065, UM276, UM408, UM520, UM370, UM291, UM139          UM122, UM087, J99, UM163, UM119, UM085, UM077, UM066, UM111, UM352          
  alpha-(1,3)-fucosyltransferase       WP_015646026.1         0                                       6 (50.0%)                                                10 (83.3%)                                                                  0.001[\*](#t005fn001){ref-type="table-fn"}
                                                                                                      UM065, UM408, UM023, UM520, UM370, UM291                 UM122, UM087, J99, UM163, UM119, UM085, UM096, UM077, UM066, UM111          

\* p-value\<0.05 is considered statistically significant

Discussion {#sec015}
==========

The identification of a set of genes that partition the good biofilm forming *H*. *pylori* strains from their poor biofilm forming counterparts demonstrate that biofilm formation phenotype is influenced by multiple genetic factors of the bacteria. Motility and adhesion capabilities apparently are critical for the initiation of biofilm formation (and probably the subsequent propagation of biofilm).

The movement ability by different species of bacteria is linked to their ability to colonize various ecological niches, and is frequently related to pathogenesis and biofilm formation. The gene encoding for hypothetical protein K747_06625 is predicted to contain ParB-like and HNH nuclease domains. In *Actinomyces oris* K20, genes containing ParB-like nuclease domain has been shown to be involved in the formation of meshwork-like structures, which are found in some biofilm-producing bacteria \[[@pone.0166835.ref032]\]. In *P*. *aeruginosa*, *par* mutants have been observed to be impaired in motility suggesting a direct or indirect role of Par proteins in regulation of these processes \[[@pone.0166835.ref033]\]. ParA/ParB family of proteins together with the centromere-like DNA sequence *parS* is involved in chromosome and plasmid partitioning during bacterial cell division. In the absence of ParB, ParA is most probably in its dimeric state bound with ATP proficient to bind non-specifically to DNA \[[@pone.0166835.ref034]\]. Furthermore, *par* mutation also induced genes induced involve in c-di-GMP turnover and signaling \[[@pone.0166835.ref033]\]. Cyclic-di-GMP (cyclic diguanylate) is an important messenger ubiquitous in bacterial cells controlling various processes, e.g. switch between the motile planktonic and biofilm lifestyles of bacteria, virulence of animal and plant pathogens, antibiotic production, progression through the cell cycle and other cellular functions \[[@pone.0166835.ref034]\].

Another gene-of-interest encodes for a flagellar protein, which is also involved in bacterial motility. It is believed that the presence of flagella provide motility that aids kinetics of biofilm formation \[[@pone.0166835.ref035]\]. Motility provides by flagella enhance the recruitment of planktonic cells to the biofilm \[[@pone.0166835.ref036]\]. Besides, the adhesive properties of flagella proteins might also promote biofilm formation in *H*. *pylori*. This was supported by previous studies that demonstrate that *Campylobacter jejuni* flagella are needed for the initiation of biofilm formation by mediating adhesion on the surface \[[@pone.0166835.ref037]\]. In one study, microcolonies were formed on a coverslip with flagella forming bridges between organisms \[[@pone.0166835.ref038]\]. During initial reversible attachment, flagella permit individual planktonic bacteria to swim toward an appropriate biotic or abiotic surface. Subsequently, during irreversible attachment, these flagella are lost and adhesive organelles became elaborated \[[@pone.0166835.ref039]\].

Biofilm forms a protective layer for Gram-negative bacteria to prevent attack by host immune system against one of its cell wall component, lipopolysaccharide (LPS) \[[@pone.0166835.ref040]\]. *H*. *pylori* alpha-(1,3)-fucosyltransferase, one of the many genes that involved in *H*. *pylori* LPS synthesis \[[@pone.0166835.ref041]\], is also predicted to contain the biofilm formation protein (YliH/bssR) domain, which has been shown to be induced in *Escherichia coli* biofilms \[[@pone.0166835.ref042]\]. In addition, *H*. *pylori*, alpha-(1,3/4)-fucosyltransferase is required for fucosylation of both type I (Le^a^) and type II (Le^x^) Lewis antigens \[[@pone.0166835.ref043]\]. The adhesive properties of Lewis X antigen enable first colonist to adhere to the surface of the liquid through weak adhesion force in the formation of biofilm \[[@pone.0166835.ref044]\].

One of the proteins found to be prevalent with good biofilm forming strains encodes for a *cag* pathogenicity islands protein. CagA protein, encoded by *cag* pathogenicity islands, has been identified to be induced in *H*. *pylori* biofilms \[[@pone.0166835.ref045]\]. CagA, which serves as a virulent factor of *H*. *pylori*, is injected into the host through the type IV secretion system and affect the individual \[[@pone.0166835.ref046]\]. Type IV secretion system-mediated transfer is essential in direct cell-cell contact \[[@pone.0166835.ref047]\]. It is believed that this direct cell-cell contact can control the biofilm behavior in *H*. *pylori* \[[@pone.0166835.ref048]\]. Furthermore, CagE, another protein encoded by the *cag* pathogenicity islands, has also been reported to be involved in the *H*. *pylori* biofilm formation \[[@pone.0166835.ref015],[@pone.0166835.ref048]\]. *cagE* encodes for a cytoplasmic ATPase to allow the translocation of CagA protein that induces the gastric epithelial cells to secrete interleukin-8 (IL-8) and activate many intracellular signaling pathway \[[@pone.0166835.ref025]\]. Thus, the *cag* pathogenicity island may play an important role in *H*. *pylori* biofilm formation. Besides its role in bacteria-host interaction, CagA and the *cag* pathogenicity island may also have a role to play in bacteria-bacteria interaction in *H*. *pylori* biofilm formation.

Conclusion {#sec016}
==========

Using a comparative genomics approach, data from this study suggest that biofilm formation in *H*. *pylori* might be influenced by multiples genes. Good and poor biofilm forming strain may differ genetically in terms of motility, adhesion and bacteria-bacteria interactions, which are important during the initiation of biofilm formation.
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